Business

Eli Lilly eyes strategic expansion through aggressive dealmaking

Flush with cash from its dominant weight-loss portfolio, Eli Lilly is signaling a shift toward rapid acquisition. Jacob Van Naarden, who now oversees business development alongside the oncology unit, suggests the pharmaceutical giant is prepared to move into entirely new therapeutic categories to secure its long-term growth.

Macy's Posts Best First Quarter in Years, Bolstering Fiscal Outlook

Macy's reported its strongest first-quarter comparable sales growth in four years, signaling momentum in its multi-year turnaround strategy. The department store chain outperformed Wall Street expectations, prompting CEO Tony Spring to raise full-year guidance despite lingering concerns over macroeconomic instability and shifting consumer spending patterns.

Ulta Beauty shares climb on earnings beat and raised outlook

A 7% surge in after-hours trading greeted Ulta Beauty on Tuesday, as the retailer defied wider retail headwinds to post quarterly results that comfortably outpaced Wall Street’s expectations. The company reported a strong start to the fiscal year, prompting leadership to lift its full-year earnings guidance despite a cooling consumer landscape.

Goldman Sachs CEO Sees Peak Optimism as AI Giants Eye IPOs

Audemars Piguet market value holds firm despite Swatch collaboration

Victoria’s Secret Shares Surge 40% After Sales Outlook Boost

McDonald's pivots to "NEXT" strategy to defend market dominance

UAW walkout at Michigan parts plant hits GM truck supply

Berkshire Hathaway bets $6.8 billion on Taylor Morrison recovery

Barry Diller Eyes Full Control of MGM Resorts in $18 Billion Bid

The Billion-Dollar Hangover: How AI Is Stranding Pre-ChatGPT Unicorns

Retailers brace for a spending slump as tax refund tailwinds fade

Trump pivots to fast-track psychedelic therapies for mental health

Ivonescimab trial data shows survival gains in lung cancer patients

Disney’s Advertising Push Centers on the Power of Fandom

South Asian Music Emerges as the Next Global Investment Frontier

Generation Z Emerges as the New Engine of Box Office Growth

Replimune revives melanoma drug bid after FDA leadership shift

Asian snack brands break out of the ethnic aisle

CVS Caremark Expands Obesity Drug Access with Zepbound Reinstatement

Aerie Drives Growth as American Eagle Struggles With Brand Identity

Gap Shares Slide 14% as Old Navy Sales Miss Targets

Disney Challenges FCC Over Early Broadcast License Renewals

Costco Reports Record Fuel Demand as Inflation Drives Member Loyalty

Trinity Way DMCC Marks Continued Growth Following Corporate Development Milestones